Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Patel, SP; Othus, M; Chen, YB; Wright, GP; Yost, KJ; Hyngstrom, JR; Hu-Lieskovan, S; Lao, CD; Fecher, LA; Truong, TG; Eisenstein, JL; Chandra, S; Sosman, JA; Kendra, KL; Wu, RC; Devoe, CE; Deutsch, GB; Hegde, A; Khalil, M; Mangla, A; Reese, AM; Ross, MI; Poklepovic, AS; Phan, GQ; Onitilo, AA; Yasar, DG; Powers, BC; Doolittle, GC; In, GK; Kokot, N; Gibney, GT; Atkins, MB; Shaheen, M; Warneke, JA; Ikeguchi, A; Najera, JE; Chmielowski, B; Crompton, JG; Floyd, JD; Hsueh, E; Margolin, KA; Chow, WA; Grossmann, KF; Dietrich, E; Prieto, VG; Lowe, MC; Buchbinder, EI; Kirkwood, JM; Korde, L; Moon, J; Sharon, E; Sondak, VK; Ribas, A
Patel, SP (通讯作者)，Univ Texas A&M Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.
NEW ENGLAND JOURNAL OF MEDICINE, 2023; 388 (9): 813
